(Q35583440)

9 August 2017

1 reference

title

Chronic beryllium disease: immune-mediated destruction with implications for organ-specific autoimmunity (English)

1 reference

9 August 2017

Chronic beryllium disease: immune‐mediated destruction with implications for organ‐specific autoimmunity (English)

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

1 April 2024

author name string

A. P. Fontenot

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617028

1 April 2024

B. L. Kotzin

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14617028

1 April 2024

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=14617028

1 April 2024

publication date

1 December 2003

1 reference

full work available at URL

9 August 2017

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1046%2Fj.1399-0039.2003.00160.x

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

https://onlinelibrary.wiley.com/doi/pdf/10.1046/j.1399-0039.2003.00160.x

1 April 2024

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

1 April 2024

1 reference

9 August 2017

volume

62

1 reference

9 August 2017

issue

6

1 reference

9 August 2017

page(s)

449-458

1 reference

Beryllium presentation to CD4+ T cells underlies disease-susceptibility HLA-DP alleles in chronic beryllium disease

9 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Chronic beryllium disease: T cell recognition of a metal presented by HLA-DP.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Beryllium sensitization and disease among long-term and short-term workers in a beryllium ceramics plant

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Immunogenetic basis of environmental lung disease: lessons from the berylliosis model

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Beryllium sensitivity is linked to HLA-DP genotype

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Crystal structure of the human class II MHC protein HLA-DR1 complexed with an influenza virus peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Production of soluble MHC class II proteins with covalently bound single peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

HLA-DQ beta gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Beryllium screening raises ethical issues.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

HLA-DPB1 and chronic beryllium disease: a HuGE review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

New perspectives of CD28-B7-mediated T cell costimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

21 January 2018

The B7-CD28 superfamily

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

CD28-mediated signalling co-stimulates murine T cells and prevents induction of anergy in T-cell clones

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

CD28 costimulation independence of target organ versus circulating memory antigen-specific CD4+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Potential binding modes of beryllium with the class II major histocompatibility complex HLA-DP: a combined theoretical and structural database study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Machining risk of beryllium disease and sensitization with median exposures below 2 micrograms/m3

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1399-0039.2003.00160.X

Delayed chemical pneumonitis in workers exposed to beryllium compounds

21 January 2018

3

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Epidemiology of beryllium intoxication

1 April 2024

4

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Epidemiology of beryllium sensitization and disease in nuclear workers

1 April 2024

7

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Epidemiological aspects of beryllium-induced nonmalignant lung disease: a 30 year update

1 April 2024

12

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Pathologic and immunologic alterations in early stages of beryllium disease. Re-examination of disease definition and natural history

1 April 2024

14

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Nonoccupational beryllium disease masquerading as sarcoidosis: identification by blood lymphocyte proliferative response to beryllium

1 April 2024

15

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

HLA-DPB1 glutamate 69: a genetic marker of beryllium disease

1 April 2024

18

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Interaction of genetic and exposure factors in the prevalence of berylliosis

1 April 2024

19

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Human leukocyte antigen Class II amino acid epitopes: susceptibility and progression markers for beryllium hypersensitivity

1 April 2024

22

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Target organ localization of memory CD4(+) T cells in patients with chronic beryllium disease

1 April 2024

24

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

HLA-DP allele-specific T cell responses to beryllium account for DP-associated susceptibility to chronic beryllium disease

1 April 2024

25

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

The I-Ag7 MHC class II molecule linked to murine diabetes is a promiscuous peptide binder

1 April 2024

30

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Major histocompatibility complex-directed susceptibility to rheumatoid arthritis

1 April 2024

31

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Expansions of T-cell subsets expressing particular T-cell receptor variable regions in chronic beryllium disease

1 April 2024

35

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Biased accumulation of T lymphocytes with "memory"-type CD45 leukocyte common antigen gene expression on the epithelial surface of the human lung

1 April 2024

36

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Maintenance of alveolitis in patients with chronic beryllium disease by beryllium-specific helper T cells

1 April 2024

37

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Beryllium skin patch testing to analyze T cell stimulation and granulomatous inflammation in the lung.

1 April 2024

39

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

A cell culture model for T lymphocyte clonal anergy

1 April 2024

44

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Cells that present both specific ligand and costimulatory activity are the most efficient inducers of clonal expansion of normal CD4 T cells.

1 April 2024

45

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

CD4+ CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity

1 April 2024

47

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells

1 April 2024

48

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

Costimulation of T-cell activation and virus production by B7 antigen on activated CD4+ T cells from human immunodeficiency virus type 1-infected donors

1 April 2024

49

1 reference

https://api.crossref.org/works/10.1046/J.1399-0039.2003.00160.X

1 April 2024

Identifiers

1 reference

9 August 2017

1 reference